Hcv ns3-ns4a protease resistance mutants

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/18 (2006.01) C12N 15/51 (2006.01) C12Q 1/37 (2006.01) G01N 33/50 (2006.01) G06F 17/50 (2006.01)

Patent

CA 2551074

The present invention is directed to mutants of HCV NS3/4A protease. More particularly, the present invention identifies mutant of HCV NS3/4A protease that are resistant to drug treatment.

L'invention concerne des mutants de la protéase HCV NS3/4A. L'invention concerne, en particulier, l'invention permet d'identifier des mutants des protéases HCV NS3/4A qui sont résistants au traitement médicamenteux.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hcv ns3-ns4a protease resistance mutants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hcv ns3-ns4a protease resistance mutants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hcv ns3-ns4a protease resistance mutants will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1436098

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.